Question

Mark the correct option:
i) An oral contraceptive for females developed by CDRI, Lucknow is __________.
ii) Family planning programmes were initiated in ________.
iii) There is statutory ban (regulated by law) on ___________ in India for sex determination to check increasing female foeticides.

• A. i-Saheli, ii-1951, iii-amniocentesis
• B. i-Mala-D, ii-1961, iii-amniocentesis
• C. i-Saheli, ii-1941, iii-amniocentesis
• D. i-Mala-D, ii-1971, iii-amniocentesis

Answer 1

The correct option is A i-Saheli, ii-1951, iii-amniocentesis

Saheli (also called Centchroman) is a non-steroidal contraceptive (prevents pregnancy) pill containing ormeloxifene which acts on estrogen receptors.

It was first developed by the Central Drug Research Institute (CDRI) in Lucknow, India.

India was one of the first countries to adopt reproductive health as a social goal. These programmes were termed ‘family planning’ programmes which kickstarted in 1951.

Amniocentesis is a medical procedure which is employed primarily in diagnosis of chromosomal abnormalities in foetus, foetal infections as well as for sex determination. There is statutory ban (regulated by law) on amniocentesis in India for sex determination to check increasing female foeticides (killing of female foetus). This procedure can only be used for checking up on health of developing foetus when necessary and not for sex determination.

Mala-D is a medicine used to prevent pregnancy. It does so by preventing the release of the egg and thereby its subsequent fertilisation by the sperm.